FeNO (Fractional Exhaled Nitric Oxide) Detection System

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.

Diagnostic system detecting nitric oxide in exhaled breath to evaluate airway inflammation and diagnose primary ciliary dyskinesia. Provides non-invasive assessment of respiratory tract conditions.

System for detecting nitric oxide and carbon dioxide levels in human breath samples. Supports both oral and nasal breathing modes with measurement range of 1ppb to 3500ppb. Used for non-invasive monitoring of respiratory and circulatory parameters.

A device specialized in detecting and measuring biomarkers present in exhaled breath. This technology identifies specific compounds in exhaled air to provide diagnostic information about patient health conditions.

A fluorescent probe for detection and measurement of nitric oxide in biological samples. Enables assessment of NO-mediated signaling and endothelial function.

Breath test device measuring carbon monoxide levels to assess red blood cell lifespan and diagnose hemolysis. Supports clinical evaluation of anemia, jaundice, and abdominal pain through non-invasive exhaled air analysis.

Fractional exhaled nitric oxide (FeNO) measurement system for non-invasive assessment of airway inflammation. Utilized in diagnosis and monitoring of asthma, COPD, and chronic respiratory conditions with high-precision sensing technology.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.

Fenobreath is a diagnostic test device for monitoring respiratory function and airway health. It measures exhaled nitric oxide (FeNO) levels to aid in asthma diagnosis, assessment, and management. The device provides rapid, non-invasive testing suitable for clinical and point-of-care settings.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.